| pubmed-article:3931676 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3931676 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
| pubmed-article:3931676 | lifeskim:mentions | umls-concept:C0012854 | lld:lifeskim |
| pubmed-article:3931676 | lifeskim:mentions | umls-concept:C0032405 | lld:lifeskim |
| pubmed-article:3931676 | lifeskim:mentions | umls-concept:C0547040 | lld:lifeskim |
| pubmed-article:3931676 | lifeskim:mentions | umls-concept:C0456389 | lld:lifeskim |
| pubmed-article:3931676 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:3931676 | lifeskim:mentions | umls-concept:C1514873 | lld:lifeskim |
| pubmed-article:3931676 | pubmed:issue | 16 | lld:pubmed |
| pubmed-article:3931676 | pubmed:dateCreated | 1985-12-5 | lld:pubmed |
| pubmed-article:3931676 | pubmed:abstractText | Poly(ADP-ribose) polymerase requires DNA as an essential enzyme activator. Using enzyme purified from lamb thymus and double-stranded deoxynucleotide oligomers of defined length, we conducted studies to identify the smallest size DNA fragment capable of successfully activating poly(ADP-ribose) polymerase. These studies revealed that a double-stranded hexadeoxynucleotide activated the enzyme 30% as effectively as highly polymerized calf thymus DNA and a double-stranded octadeoxynucleotide activated the enzyme even more effectively than calf thymus DNA. When histone H1 was also included in the reaction system, the enzyme could be activated by even smaller DNA fragments. Thus, in the presence of histone H1, a double-stranded tetradeoxynucleotide activated the enzyme 25% as effectively as calf thymus DNA, and a double-stranded hexadeoxynucleotide was equally as effective as calf thymus DNA. The time courses for activation and the stabilities of the products were identical when the enzyme was activated by a double-stranded hexadeoxynucleotide or by calf thymus DNA. Double-stranded oligodeoxynucleotides containing dephosphorylated termini were more effective activators than those containing 3'-phosphorylated termini which in turn were more effective than those containing 5'-phosphorylated termini. | lld:pubmed |
| pubmed-article:3931676 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3931676 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3931676 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3931676 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3931676 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3931676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3931676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3931676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3931676 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3931676 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:3931676 | pubmed:issn | 0006-2960 | lld:pubmed |
| pubmed-article:3931676 | pubmed:author | pubmed-author:PetzoldS JSJ | lld:pubmed |
| pubmed-article:3931676 | pubmed:author | pubmed-author:BergerN ANA | lld:pubmed |
| pubmed-article:3931676 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3931676 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:3931676 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:3931676 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3931676 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3931676 | pubmed:pagination | 4352-5 | lld:pubmed |
| pubmed-article:3931676 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:3931676 | pubmed:meshHeading | pubmed-meshheading:3931676-... | lld:pubmed |
| pubmed-article:3931676 | pubmed:meshHeading | pubmed-meshheading:3931676-... | lld:pubmed |
| pubmed-article:3931676 | pubmed:meshHeading | pubmed-meshheading:3931676-... | lld:pubmed |
| pubmed-article:3931676 | pubmed:meshHeading | pubmed-meshheading:3931676-... | lld:pubmed |
| pubmed-article:3931676 | pubmed:meshHeading | pubmed-meshheading:3931676-... | lld:pubmed |
| pubmed-article:3931676 | pubmed:meshHeading | pubmed-meshheading:3931676-... | lld:pubmed |
| pubmed-article:3931676 | pubmed:meshHeading | pubmed-meshheading:3931676-... | lld:pubmed |
| pubmed-article:3931676 | pubmed:meshHeading | pubmed-meshheading:3931676-... | lld:pubmed |
| pubmed-article:3931676 | pubmed:meshHeading | pubmed-meshheading:3931676-... | lld:pubmed |
| pubmed-article:3931676 | pubmed:meshHeading | pubmed-meshheading:3931676-... | lld:pubmed |
| pubmed-article:3931676 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:3931676 | pubmed:articleTitle | Identification of minimal size requirements of DNA for activation of poly(ADP-ribose) polymerase. | lld:pubmed |
| pubmed-article:3931676 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3931676 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3931676 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3931676 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3931676 | lld:pubmed |
